Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0001
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT - Market closed
Anthera Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
21
Market Cap
26.18
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 385.44B |
Johnson & Johnson | 86.58B |
Merck & Co. | 62.48B |
AbbVie | 55.00B |
AstraZeneca | 49.13B |
Novartis AG | 48.86B |
Thermo Fisher | 42.35B |
Abbott Laboratories | 40.73B |
ANTH News
- 3 years ago - AM Best Assigns Issue Credit Ratings to Anthem, Inc.'s New Senior Unsecured Notes - Business Wire
- 3 years ago - AM Best Comments on Credit Ratings of Anthem, Inc. and Its Subsidiaries Following MMM Holdings, LLC Acquisition Announcement - Business Wire